Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2012
03/13/2012CA2549824C Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia
03/13/2012CA2546688C Device for the transdermal administration of active ingredients
03/13/2012CA2536499C Buccal formulations of galanthamine and uses thereof
03/13/2012CA2530772C Composition and method for the treatment of water related ear disorders
03/13/2012CA2525615C Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine
03/13/2012CA2519523C Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
03/13/2012CA2513595C Thin aqueous cataplasm
03/13/2012CA2513144C Phospholipid derivative and method for producing the same
03/13/2012CA2509976C Modified release pharmaceutical composition
03/13/2012CA2509670C Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
03/13/2012CA2499878C Solid pharmaceutical formulations comprising telmisartan
03/13/2012CA2498207C Gel-stabilized nanoparticulate active agent compositions
03/13/2012CA2487648C Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
03/13/2012CA2470116C Catheter for cell delivery in tissue
03/13/2012CA2463358C Prolonged release biodegradable microspheres and method for preparing same
03/13/2012CA2459811C Modified peptides and their use for the treatment of autoimmune diseases
03/13/2012CA2442854C Hsa-free formulations of interferon-beta
03/13/2012CA2402191C Use of insulin for the treatment of cartilagenous disorders
03/08/2012WO2012031293A1 Compositions and methods for the treatment of cancer
03/08/2012WO2012031205A2 Lipid-polymer hybrid particles
03/08/2012WO2012031175A2 Nanoparticle-based tumor-targeted drug delivery
03/08/2012WO2012031164A2 Drug delivery by carbon nanotube arrays
03/08/2012WO2012031046A2 Lipids suitable for liposomal delivery of protein-coding rna
03/08/2012WO2012031043A1 Pegylated liposomes for delivery of immunogen-encoding rna
03/08/2012WO2012030927A2 Modified-release dosage forms of 5-ht2c agonists useful for weight management
03/08/2012WO2012030901A1 Small liposomes for delivery of immunogen-encoding rna
03/08/2012WO2012030664A1 Dry powder formulations and methods for treating pulmonary diseases
03/08/2012WO2012030647A1 Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
03/08/2012WO2012030645A1 Respirably dry powder comprising calcium lactate, sodium chloride and leucine
03/08/2012WO2012030513A2 Methods of treating bacterial infections through pulmonary delivery of fusidic acid
03/08/2012WO2012030371A1 Immediate release drugs for high ph environments
03/08/2012WO2012030309A2 Formulation of calcium channel blocker
03/08/2012WO2012030308A2 Formulation comprising cellobiose
03/08/2012WO2012029913A1 Oral preparation
03/08/2012WO2012029838A1 Orally disintegrating tablet
03/08/2012WO2012029831A1 Adhesive sheet, use thereof, and method of adhering the adhesive sheet
03/08/2012WO2012029827A1 Process for producing drug—block-copolymer composite and pharmaceutical product containing same
03/08/2012WO2012029820A1 Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation
03/08/2012WO2012029456A1 Oil-in-water emulsion composition containing poorly-soluble drug, and method for manufacturing same
03/08/2012WO2012029348A1 Granules containing bitter drug and orally disintegrating tablet
03/08/2012WO2012029325A1 Percutaneous absorbent and adhesive sheet for skin patch
03/08/2012WO2012029160A1 Stabilized polyphenol solution and method for stabilizing polyphenol solution
03/08/2012WO2012029148A1 Freeze-dried recombinant human bone morphogenetic protein-2 preparation
03/08/2012WO2012029127A1 Skin patch sheet, utilization of same, and method for applying skin patch sheet
03/08/2012WO2012029097A1 Transdermal preparation
03/08/2012WO2012029076A2 Stable pharmaceutical composition
03/08/2012WO2012029046A1 Method for testing the effect of compounds on cellular systems
03/08/2012WO2012028966A2 Combination dosage compositions comprising a cholesterol-lowering agent, a renin-angiotensin system inhibitor, an antioxidant agent and an antiplatelet agent for treatment and prevention of cardiovascular disease
03/08/2012WO2012028934A1 Pharmaceutical composition comprising metformin and pioglitazone
03/08/2012WO2012028922A2 Controlled release pharmaceutical compositions of milnacipran
03/08/2012WO2012028863A1 Biocompatible compositions for tissue augmentation
03/08/2012WO2012028745A1 Pharmaceutical composition suitable for use in a dry powder inhaler
03/08/2012WO2012028733A1 A water-in-oil type emulsion for treating a disease of the eye
03/08/2012WO2012028702A1 Hard capsules based on starch, and also dip-coating composition, dipping bath and process for preparing same
03/08/2012WO2012028698A1 Mesalazine tablet having improved dissolution
03/08/2012WO2012028683A1 Antibody gel system for sustained drug delivery
03/08/2012WO2012028663A1 Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
03/08/2012WO2012028662A1 Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
03/08/2012WO2012028623A1 Crosslinked polysaccharide beads and their biomedical uses
03/08/2012WO2012028585A1 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
03/08/2012WO2012028526A2 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
03/08/2012WO2012028525A2 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012WO2012028524A2 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012WO2012028340A1 Preventive ointment for diabetic foot
03/08/2012WO2012028319A1 Tamper resistant dosage form comprising inorganic salt
03/08/2012WO2012028318A1 Tamper resistant dosage form comprising an anionic polymer
03/08/2012WO2012028317A1 Tamper resistant dosage form comprising an anionic polymer
03/08/2012WO2012028315A1 A stabilizer for the preparation of a dry polio injectable vaccine composition
03/08/2012WO2012028101A1 Liquid compositions of insoluble drugs and preparation methods thereof
03/08/2012WO2012028056A1 A clinical preparation of scutellarin and the preparation method thereof
03/08/2012WO2012027968A1 Panaxatriol saponins enteric pellet, capsule comprising same and method for preparing same
03/08/2012WO2012027882A1 Pharmaceutical composition for treating insomnia and preparation method thereof
03/08/2012WO2012012388A3 Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy
03/08/2012WO2012009405A3 Skin care compositions
03/08/2012WO2012009341A3 Tissue scaffolds for controlled release of active agents
03/08/2012WO2012004408A3 Multi-layer tablet formation by adhering tablet bodies together
03/08/2012WO2012002986A3 Decellularized and delipidized extracellular matrix and methods of use
03/08/2012WO2011162421A3 Foam-type external skin preparation
03/08/2012WO2011152652A3 Aceclofenac slow-release preparation providing an optimum pharmacological clinical effect when administered once a day
03/08/2012WO2011146804A3 Gm3 ganglioside replacement therapy
03/08/2012WO2011146032A3 Effervescent formulations
03/08/2012WO2011143187A3 Lactoferrin -based biomaterials for tissue regeneration and drug delivery
03/08/2012WO2011142731A3 Formulations comprising a third generation cephalosporin and clavulanic acid
03/08/2012WO2011142621A3 Pharmaceutical formulation in the form of bilayered tablets comprising hmg-coa reductase inhibitor and irbesartan
03/08/2012WO2011140550A3 Immunogen adherence and method of making and using same
03/08/2012WO2011139796A3 Self-folding sub-centimeter structures
03/08/2012WO2011139684A3 Nicotine-containing pharmaceutical compositions
03/08/2012WO2011139103A3 Method for producing a water-insoluble gel composition and a water-insoluble gel produced thereby
03/08/2012WO2011135591A3 Novel tablet composition of polyallylamine polymers
03/08/2012WO2011133475A3 Compositions and method for the treatment of multiple myeloma
03/08/2012WO2011127181A3 System and method for the release of nitric oxide using nanoscale media
03/08/2012WO2011123619A3 Permeable mixtures, methods and compositions for the skin
03/08/2012WO2011122923A3 Long-acting interferon beta formulation using immunoglobulin fragment
03/08/2012WO2011122922A3 Long-acting human follicle-stimulating hormone formulation using immunoglobulin fragment
03/08/2012WO2011122921A3 An insulin conjugate using an immunoglobulin fragment
03/08/2012WO2011109200A9 The use of rhamnolipids as a drug of choice in the case of nuclear disasters in the treatment of the combination radiation injuries and illnesses in humans and animals
03/08/2012WO2011090349A9 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
03/08/2012WO2011089126A3 Novel retigabine composition
03/08/2012WO2011080141A3 Degradable removable implant for the sustained release of an active compound
03/08/2012WO2011048563A3 Orally disintegrating tablets of betahistine
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 2991